18th Sep 2026 07:59
(Alliance News) - UK retail sales rebound in August and beat market expectations. AstraZeneca's efzimfotase alfa receives 'Priority Review' in the US for the treatment of hypophosphatasia, while Softcat raises GBP354 million to help fund its USD1.05 billion acquisition of GDT. Read More
